Image
Meeting Series

BRIDGE HCV

Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV

Clinical Practice Guideline

Considerations for Antiretroviral Use in Patients With Coinfections: Hepatitis C Virus/HIV Coinfection.

US Department of Health and Human Services (DHHS). Last updated December 2019.

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C.

American Association for the Study of Liver Diseases (AASLD)/Infectious Diseases Society of America (IDSA), Last updated November 2019.

Final Recommendation Statement. Hepatitis C Virus Infection in Adolescents and Adults: Screening.

US Preventive Services Task Force. March 2020.

Clinical Resources

A Guide to Comprehensive Hepatitis C Counseling and Testing.

Centers for Disease Control and Prevention (CDC).

Appeals letter template for use following HCV treatment denial.

Hepatitis C Online Tools and Calculators: APRI.

Hepatitis C Online: University of Washington

Hepatitis C Online Tools and Calculators: FIB-4.

Hepatitis C Online: University of Washington

HEP Drug Interactions.

University of Liverpool.

National Harm Reduction Coalition.

PREP-C: Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment.

Mount Sinai School of Medicine.

Rural Health Information Hub.

Action and Advocacy

Center for Health Law and Policy Innovation (CHLPI)

CHLPI advocates for legal, regulatory, and policy reforms to improve the health of underserved populations. It has played a pivotal role in removing Medicaid restrictions on HCV treatment.

Hepatitis Education Project (HEP)

HEP provides support, education, advocacy, and direct services for people affected by hepatitis, and works to raise hepatitis awareness among patients, medical providers, and the general public.

National Hepatitis Corrections Network (NHCN)

NHCN, managed by HEP, supports a public health approach to hepatitis education, prevention, testing, and treatment in prisons and jails.

National Viral Hepatitis Roundtable

National Viral Hepatitis Roundtable (NVHR) is a coalition working together to eliminate hepatitis B and C in the U.S. It offers practical online resources for practice management.

Substance Abuse and Mental Health Services Administration (SAMHSA): Locator Map

SAMHSA provides an interactive national map that facilitates identification of local resources and services for substance use and mental health disorders.

Patient Resources

The BodyPro — Project Inform

Project Inform promotes the development of effective HIV and HCV therapies; supports patients’ informed choices about their health; advocates for quality, affordable health care; and addresses medical strategies that prevent new infections.

Hepatitis C Information Center

The American Liver Foundation’s Hepatitis C Information Center website is a dedicated online information and resource center created in support of individuals impacted by HCV infection.

HepatitisC.net

HepatitisC.net is a website for people living with HCV that offers education, tools, and resources. Articles are written by people living with or cured of HCV, patient advocates, and medical providers.

Hepatitis C Questions and Answers for the Public

Centers for Disease Control and Prevention (CDC). Last reviewed April 2020.The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This patient-directed website addresses basics across the HCV clinical continuum.

Suggested Readings

Rural risk environments for hepatitis C among young adults in Appalachian Kentucky.

Cloud DH, et al. Int J Drug Policy. 2019;72:47-54.

Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C.

Havens JR, et al. BMJ Open. 2021;11:e041490.

Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy.

Kushner T, Reau N. J Hepatol. 2021;74(3):734-741.

Hepatitis C testing among perinatally exposed infants.

Lopata SM, et al. Pediatrics. 2020;145(3):e20192482.

Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—the practitioner experience.

Marshall AD, et al. Drug Alcohol Depend. 2020;206:107705.

Concurrent initiation of hepatitis C and opioid use disorder treatment in people who inject drugs.

Rosenthal ES, et al. Clin Infect Dis. 2020;71(7):1715-1722.

Activity
HCV in People Who Inject Drugs

A Call to Action for Frontline Providers

Activity
Addressing the Real-World Challenge of HCV Cure in People Who Inject Drugs

Opportunities for Current and New HCV Treaters

Relevant Resources

PrEP for Your Patients’ Needs

The PCPs Role in Preventing HIV

Value-Based HIV Formularies

Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care

Targeting NASH

Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis

Hepatitis C is Curable

Got it? Treat it!

Real-World Issues in HIV Prevention & Treatment

The Critical Role of the Community Pharmacist

BLOCK HIV/HCV

Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.

Evolving Models of HIV Care

Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box

The Nexus of NASH and Type 2 Diabetes Mellitus

The Emerging Role of the Diabetologist

Updates in HCV Screening and Treatment

Key Issues Impacting OB/GYN Practice

The Big Picture of IBD

An Interactive Experience Highlighting Recent Clinical Advances

Clinical Issues in Chronic Liver Disease

Hot Topics in HBV, HCV, and NASH

The Changing Landscape of IBD

Emerging Concepts in Patient Management

The Big (& Small) Picture of Nonalcoholic Steatohepatitis

Building Your Understanding to Combat a Growing Problem

Evolving Models of HIV Care

Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice

Assessing Your Patients for HCV and HIV

Why It Matters in OB/GYN Practice Today

HIV as a Chronic Disease

A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities

The Pursuit of Hepatitis C Elimination

How the Pharmacist Can Make a Difference

Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV

Understanding the Growing Syndemic — Opioids, HCV, and HIV

Trends and Updates in IBD

Appraising the Therapeutic Armamentarium in Moderate and Severe Disease

Stepping Up to the Challenge

The PCP’s Role in HCV Elimination

The Changing Landscape of HIV Prevention

What the Pharmacist Needs to Know about PrEP

Evolving Models of HIV Care (Volume 3)

The Rapid ART Standard of Care: From Evidence to Healthcare Equity

HIV Updates for Pharmacy Practice

Maximizing Your Role to Impact Patient Outcomes

Case Challenges in HIV Medicine

Benefits, Barriers, & Best Practices in an Advancing Field

Challenges and Opportunities in HIV

Practical Solutions Across the Spectrum of Care

Expanding HIV Prevention in Colorado—and Nationwide

A PEP/PrEP Training Guide for Pharmacists

Setting a Course for the Optimal Management of IBD

An Interactive Learning Experience

Optimizing Advanced Therapies in Ulcerative Colitis: Is Your Practice Up to Date?

A Focus on Clinical Evidence and Guideline Recommendations

Treating Hepatitis C in the Primary Care Setting

A Critical Step Toward HCV Elimination

Honing Clinical Skills in HIV Treatment

Considering the Patient, the Provider, and the Science

Hot Topics in HCV

A Multidisciplinary Online Mini-Curriculum

IBD Journal Club:

Volume 1: A Guided Tour of the Evidence Driving Selection of First-line Advanced Therapies in Moderate to Severe IBD

Clinical Issues in COVID-19

Debates and Discussions about Monoclonal Antibody Therapies

Minimizing Patient Risks From COVID-19

An Update on Monoclonal Antibody Therapies